Admin-Core A
管理核心A
基本信息
- 批准号:9141190
- 负责人:
- 金额:$ 21.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2020-07-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAntibody-mediated protectionConflict (Psychology)EnsureFoundationsGoalsGrantHIVIACUCIndividualInstitutional Review BoardsIntellectual PropertyLeadLeadershipMarylandNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesPrincipal InvestigatorProgress ReportsPublicationsRegulationReportingResolutionResourcesUnited States National Institutes of HealthUniversitiesabstractingdata sharingexperienceprogramspublic health relevanceresearch and development
项目摘要
Project Summary/Abstract
The Administrative Core will coordinate activities between the two projects and the scientific cores of the
Program.
The Administrative Core will provide the following functions.
1. Provide support for interactions among the projects, the cores, and the External Advisory Committee.
2. Provide support for interactions with NIAID/DAIDS Program.
3. Provide support for financial management, procurement, intellectual property management in concert
with University of Maryland Office of Research Development (ORD) and reporting for all project
activities.
4. Provide secretarial support for publications, and the submission of progress reports.
5. Provide support for institutional oversight including IRB, IBC, ORD and IACUC.
6. Provide support to manage the resolution any conflicts that might emerge within the context of the
Program.
The Administration Core is both the administrative and scientific center of the proposed Program. This Core
will oversee the scientific focus of the individual projects, ensure the scientific interplay vital to the Program's
overall goals, and manage finances and resources in a manner consistent with NIH requirements and project
needs, while ensuring compliance with IACUC, IBC, IRB, and NIH Data Sharing regulations in the conduct of
this project.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT C GALLO其他文献
ROBERT C GALLO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT C GALLO', 18)}}的其他基金
Durable Antibody Mediated Protection Against HIV
持久的抗体介导的艾滋病毒保护
- 批准号:
9141189 - 财政年份:2016
- 资助金额:
$ 21.77万 - 项目类别:
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine
FLSC 与 Tat 类毒素联合作为 HIV 预防疫苗
- 批准号:
7854606 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine
FLSC 与 Tat 类毒素联合作为 HIV 预防疫苗
- 批准号:
8134640 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine
FLSC 与 Tat 类毒素联合作为 HIV 预防疫苗
- 批准号:
7944078 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
Institute of Human Virology Annual Meeting 2002-2004
人类病毒学研究所2002-2004年年会
- 批准号:
6581022 - 财政年份:2002
- 资助金额:
$ 21.77万 - 项目类别:
MECHANISMS OF ACTION OF HAF--KAPOSI'S SARCOMA
HAF--卡波西肉瘤的作用机制
- 批准号:
6311551 - 财政年份:2000
- 资助金额:
$ 21.77万 - 项目类别:
Institute of Human Virology Annual Meeting 2004
2004年人类病毒学研究所年会
- 批准号:
6837997 - 财政年份:1999
- 资助金额:
$ 21.77万 - 项目类别:
相似海外基金
Durable Antibody Mediated Protection Against HIV
持久的抗体介导的艾滋病毒保护
- 批准号:
9141189 - 财政年份:2016
- 资助金额:
$ 21.77万 - 项目类别:
Project 2- Mechanism of How Vaccine-Elicited CD4+ T Cells Attenuate Antibody Mediated Protection
项目 2 - 疫苗诱导的 CD4 T 细胞如何减弱抗体介导的保护的机制
- 批准号:
9141193 - 财政年份:2016
- 资助金额:
$ 21.77万 - 项目类别:
Antibody-mediated protection against cell-associated HIV
抗体介导的针对细胞相关 HIV 的保护
- 批准号:
300439 - 财政年份:2013
- 资助金额:
$ 21.77万 - 项目类别:
Fellowship Programs
Role of Fc Receptor Polymorphisms in Antibody-Mediated Protection
Fc 受体多态性在抗体介导的保护中的作用
- 批准号:
8410766 - 财政年份:2012
- 资助金额:
$ 21.77万 - 项目类别:
Cell Death and Antibody-Mediated Protection from Autoimmunity
细胞死亡和抗体介导的自身免疫保护
- 批准号:
8264838 - 财政年份:2011
- 资助金额:
$ 21.77万 - 项目类别:
Cell Death and Antibody-Mediated Protection from Autoimmunity
细胞死亡和抗体介导的自身免疫保护
- 批准号:
7892627 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
Identifying epitopes that induce antibody mediated protection against foot-and-mouth disease using reverse genetics
使用反向遗传学识别诱导抗体介导的口蹄疫保护的表位
- 批准号:
BB/F009186/1 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
Research Grant
Mechanisms of non-neutralizing antibody-mediated protection from influenza virus
非中和抗体介导的流感病毒保护机制
- 批准号:
7915053 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
Mechanisms of non-neutralizing antibody-mediated protection from influenza virus
非中和抗体介导的流感病毒保护机制
- 批准号:
7643166 - 财政年份:2008
- 资助金额:
$ 21.77万 - 项目类别:
Mechanisms of non-neutralizing antibody-mediated protection from influenza virus
非中和抗体介导的流感病毒保护机制
- 批准号:
7511491 - 财政年份:2008
- 资助金额:
$ 21.77万 - 项目类别:














{{item.name}}会员




